Credit rating
Company information
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S (CVR number: 26290724) is a company from KØBENHAVN. The company recorded a gross profit of -133 kDKK in 2023. The operating profit was -133 kDKK, while net earnings were 1254 kDKK. The profitability of the company measured by Return on Assets (ROA) was 3.8 %, which can be considered weak and Return on Equity (ROE) was 3.8 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 99.7 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. NORDIC BIOTECH K/S's liquidity measured by quick ratio was 76.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 13 167.00 | ||||
Gross profit | 13 005.00 | -98.00 | - 119.00 | - 118.00 | - 133.00 |
EBIT | 13 005.00 | -1 354.00 | -6 381.00 | - 118.00 | - 133.00 |
Net earnings | 12 997.00 | -1 360.00 | -6 387.00 | -44 572.00 | 1 254.00 |
Shareholders equity total | 86 469.00 | 85 109.00 | 78 722.00 | 34 150.00 | 32 232.00 |
Balance sheet total (assets) | 86 604.00 | 85 170.00 | 78 784.00 | 34 208.00 | 32 326.00 |
Net debt | -1 036.00 | - 858.00 | - 734.00 | - 606.00 | -7 190.00 |
Profitability | |||||
EBIT-% | 98.8 % | ||||
ROA | 16.2 % | -1.6 % | -7.8 % | -78.9 % | 3.8 % |
ROE | 16.3 % | -1.6 % | -7.8 % | -79.0 % | 3.8 % |
ROI | 16.3 % | -1.6 % | -7.8 % | -79.0 % | 3.8 % |
Economic value added (EVA) | 13 010.63 | -1 347.22 | -6 377.93 | - 114.88 | - 130.09 |
Solvency | |||||
Equity ratio | 99.8 % | 99.9 % | 99.9 % | 99.8 % | 99.7 % |
Gearing | |||||
Relative net indebtedness % | -6.8 % | ||||
Liquidity | |||||
Quick ratio | 7.7 | 14.1 | 11.8 | 10.4 | 76.5 |
Current ratio | 7.7 | 14.1 | 11.8 | 10.4 | 76.5 |
Cash and cash equivalents | 1 036.00 | 858.00 | 734.00 | 606.00 | 7 190.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | 6.8 % | ||||
Credit risk | |||||
Credit rating | A | BBB | BBB | BB | A |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.